Expanded population of CD1d-restricted Va24+ cells in a patient with active rheumatoid arthritis. (2014)
Attributed to:
RegenVOX: phase I/II clinical trial of stem cell based tissue engineered laryngeal implants
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.clim.2013.11.006
PubMed Identifier: 24412906
Publication URI: http://europepmc.org/abstract/MED/24412906
Type: Journal Article/Review
Volume: 150
Parent Publication: Clinical immunology (Orlando, Fla.)
Issue: 2
ISSN: 1521-6616